Atharva Infertility Centre Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-06-2024
- Paid Up Capital ₹ 0.30 M
as on 24-06-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.48 M
as on 24-06-2024
- Revenue -14.83%
(FY 2018)
- Profit 4.47%
(FY 2018)
- Ebitda -15.61%
(FY 2018)
- Net Worth 20.18%
(FY 2018)
- Total Assets 4.80%
(FY 2018)
About Atharva Infertility Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.48 M.
Umesh Marathe and Yeshwant Mane serve as directors at the Company.
- CIN/LLPIN
U85110MH2008PTC179672
- Company No.
179672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2008
- Date of AGM
28 Aug 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Atharva Infertility Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umesh Marathe | Director | 04-Mar-2008 | Current |
Yeshwant Mane | Director | 04-Mar-2008 | Current |
Financial Performance and Corporate Structure Insights of Atharva Infertility Centre.
Atharva Infertility Centre Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 14.83% decrease. The company also saw a slight improvement in profitability, with a 4.47% increase in profit. The company's net worth Soared by an impressive increase of 20.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Atharva Infertility Centre?
In 2018, Atharva Infertility Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adkar Hospital And Research Institute Private Limited
Active 16 years 11 monthsYeshwant Mane is a mutual person
Atharva Center For Assisted Reproduction Llp
Active 4 years 10 monthsYeshwant Mane is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 07 Apr 2012 | ₹2.48 M | Open |
How Many Employees Work at Atharva Infertility Centre?
Atharva Infertility Centre has a workforce of 17 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atharva Infertility Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atharva Infertility Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.